Skip to main content
. Author manuscript; available in PMC: 2017 Jul 5.
Published in final edited form as: Arthritis Care Res (Hoboken). 2011 Dec;63(12):1680–1690. doi: 10.1002/acr.20629

Figure 2.

Figure 2

Veterans Affairs Rheumatoid Arthritis (VARA) registry population with full breakdown subjects fulfilling inclusion criteria and the fraction of subjects with high (medication possession ratio (MPR) ≥0.80) and low adherence (MPR <080) to methotrexate (MTX).

*Percent of veterans from the 455 who met inclusion criteria